Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@FlashAlert_me 10
@InsiderAlerts4U 8
@SweepCastApp 7
@Tickeron 5
@MarcJacksonLA 2

Recent Tweets for ALNY

newton93420295 @newton93420295
Entries & exits Daily! Discord link below? https://t.co/nanIHuZbAL $ALNY
May 28th 2022, 7:05pm
ShortAlgoTrades @ShortAlgoTrades
$ALNY Trading Ideas | Awaiting Buy signal. 80% Profitability based on 8 trades. Profit factor is 141.28. Learn more… https://t.co/iKKcvTAenc
May 27th 2022, 7:05pm
Steve_382 @Steve_382
@mRNAdisrupts The market evidently expects $ALNY to have a better revenue growth rate than $IONS. Whether that turn… https://t.co/VSfI5KISgI
May 27th 2022, 2:05pm
mRNAdisrupts @mRNAdisrupts
$alny still trades around 19xs revenue more than 3xs that of $ions. #biotechnology #biotech @MorningstarInc… https://t.co/1HozxE18cD
May 27th 2022, 2:05pm
atimeywimey @atimeywimey
$ALNY 85.71% Profitability across 7 trades in 1 month. Profit Factor of 3.23 and rating is Bearish. Get started for… https://t.co/WDxlvcS5aM
May 27th 2022, 1:05pm
AlertTrade @AlertTrade
Trading Ideas: $ALNY with a Bullish outlook following its earnings #Stocks https://t.co/yicppdVOH8 ? FREE trade-of-… https://t.co/o81NOqATQS
May 26th 2022, 5:05pm
EpsMomentum @EpsMomentum
$ALNY with a Bullish outlook following its earnings #Stocks - #ALNY chart on @TradingView https://t.co/WojECyb808
May 26th 2022, 5:05pm
SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $ALNY with our scanner on $185 PUT Expiring: 01/20/2023 worth 27K? Start Yo… https://t.co/hyJDInuNR6
May 26th 2022, 3:05pm
TradeWithAlerts @TradeWithAlerts
Nice print for $ALNY Size: 126400 Price: 126.53 Amount: $15,993,392.00 Time: 1340 See more: https://t.co/sh8zd08y8i… https://t.co/xaRqoHJVwj
May 25th 2022, 5:05pm
SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $ALNY with our scanner on $105 PUT Expiring: 08/19/2022 worth 65K? Start Yo… https://t.co/zpVM5P1MuA
May 25th 2022, 2:05pm
LeeSinTrade1 @LeeSinTrade1
$ALNY 100% Win rate on 4 trades in 1 month. Rating is Bearish. Start Free Trial at https://t.co/z9Zossz5Nf https://t.co/0vJDf4Vi2w
May 25th 2022, 2:05pm
ShortAlgoKing @ShortAlgoKing
$ALNY 100% Win rate on 4 trades in 1 month. Rating is Bearish. ? Stock Trading Ideas by https://t.co/qchl9O5K2n https://t.co/L2vQw1Cdes
May 25th 2022, 11:05am
ShortAlgoTrades @ShortAlgoTrades
$ALNY 100% Profitability across 4 trades in 1 month. Rating is Bearish. Learn more at https://t.co/sjROqPnc9P… https://t.co/0L5J8uI2JN
May 25th 2022, 7:05am
Tickeron @Tickeron
$ALNY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/24gJswfJsg
May 24th 2022, 9:05pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam's Lumasiran Shows Clinical Benefit In Rare Kidney Disease $ALNY https://t.co/ccVORsugVw via @Benzinga
May 24th 2022, 5:05pm
newsfilterio @newsfilterio
Alnylam's Lumasiran Shows Clinical Benefit In Rare Kidney Disease $ALNY https://t.co/LpVR0tkbAd
May 24th 2022, 5:05pm
Tickeron @Tickeron
If you’re trading this week, Read This! $ALNY entered Uptrend as Momentum indicator ascends above 0 level.… https://t.co/L95HzFFrPH
May 24th 2022, 2:05pm
Briefingcom @Briefingcom
$ALNY: Alnylam Pharma presents new results from the ILLUMINATE-C phase 3 study of lumasiran in patients with... https://t.co/pqxIR92LfN
May 24th 2022, 1:05pm
MarketCurrents @MarketCurrents
$ALNY - Alnylam kidney disorder therapy Oxlumo improves cardiac measures in new data from phase 3 trial https://t.co/EsmwXiEvFI
May 24th 2022, 12:05pm
invescent @invescent
$ALNY Data indicates that the overall analyst sentiment for ALNY is bullish. Simplify the way you research stock… https://t.co/mFqwrZE3OZ
May 24th 2022, 11:05am
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on May 24, 07:00:00: Alnylam Presents New Results from the ILLUMINATE-C… https://t.co/hjaofwiOMh
May 24th 2022, 11:05am
StockNewsBot2 @StockNewsBot2
$ALNY Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Prima… https://t.co/G9lZ3tDIrq
May 24th 2022, 11:05am
FastestAlert @FastestAlert
$ALNY Alnylam Presents New Results From The ILLUMINATE-C Phase 3 Study Of Lumasiran In Patients With Advanced Prima… https://t.co/kRGKVex9mt
May 24th 2022, 11:05am
stock_titan @stock_titan
$ALNY Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Prima… https://t.co/Q5RxnRaslI
May 24th 2022, 11:05am
WebChronicleTo1 @WebChronicleTo1
$ALNY Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Prima… https://t.co/r2nrSdXwtG
May 24th 2022, 11:05am
ShadowOptions @ShadowOptions
Outside day tickers - $PENN $ALNY
May 24th 2022, 3:05am
TradeWithAlerts @TradeWithAlerts
Nice print for $ALNY Size: 259977 Price: 129.58 Amount: $33,687,819.66 Time: 1803 See more: https://t.co/sh8zd080iK… https://t.co/ZIzhhZdgMP
May 23rd 2022, 10:05pm
investor_feed @investor_feed
$ALNY 8-K Alnylam Pharmaceuticals (23 May, 4:31pm) ? Submission of Matters to a Vote of Security Holders; Fina… https://t.co/4fyKFBj6Hg
May 23rd 2022, 8:05pm
OwenMar54200817 @OwenMar54200817
$ALNY Top Analyst price target today https://t.co/2izrP1g81o
May 23rd 2022, 6:05pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam Reports More Positive Data as Vutrisiran Awaits July FDA Date | BioSpace https://t.co/6gL7xT50DP #jobs
May 23rd 2022, 1:05pm
Prof_Oak_ @Prof_Oak_
Hard to extrapolate NT-proBNP from $ALNY HEALIOS-A subgroup, as BLs do not reflect CM-predominant pop (~800ng/L vs.… https://t.co/kEqh5yijRt
May 23rd 2022, 1:05pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on May 23, 07:00:00: Alnylam Presents New 18-Month Results from Explorat… https://t.co/ZJ9MHevsFc
May 23rd 2022, 11:05am
StockNewsBot2 @StockNewsBot2
$ALNY Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investi… https://t.co/tBVpPGemWi
May 23rd 2022, 11:05am
FastestAlert @FastestAlert
$ALNY Alnylam Presents New 18-Month Results From Exploratory Cardiac Endpoints In HELIOS-A Phase 3 Study Of Investi… https://t.co/da9wVdcUxJ
May 23rd 2022, 11:05am
stock_titan @stock_titan
$ALNY Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investi… https://t.co/Uh6QQPJdsX
May 23rd 2022, 11:05am
WebChronicleTo1 @WebChronicleTo1
$ALNY Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investi… https://t.co/EO5k0THOhi
May 23rd 2022, 11:05am
MarketChmln @MarketChmln
$ALNY upcoming event May 24: H.C. Wainwright Global Investment Conference. Options expiring on June 17 that cover t… https://t.co/stayyNwtlk
May 22nd 2022, 12:05pm
Tickeron @Tickeron
$ALNY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/ILVhUUOrqe
May 22nd 2022, 9:05am
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director OLIVIER BRANDICOURT: https://t.co/JjFrIm8uQu
May 21st 2022, 10:05am
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director PHILLIP A SHARP: https://t.co/USNsJk8pbV
May 21st 2022, 7:05am
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director DENNIS A AUSIELLO: https://t.co/sfrChNLacr
May 21st 2022, 6:05am
Tickeron @Tickeron
How does this make you feel? $ALNY MACD Histogram turned positive on May 19, 2022. #AlnylamPharmaceuticals… https://t.co/ki7CNorobR
May 21st 2022, 5:05am
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director AMY W SCHULMAN: https://t.co/pLT50uhnNR
May 21st 2022, 3:05am
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director DAVID E I PYOTT: https://t.co/2TaduL0e8t
May 20th 2022, 10:05pm
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director MARGARET A HAMBURG: https://t.co/Uup0Rezgm7
May 20th 2022, 9:05pm
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director MARSHA FANUCCI: https://t.co/RYoY3Y6RdV
May 20th 2022, 9:05pm
InsiderAlerts4U @InsiderAlerts4U
$ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director COLLEEN F REITAN: https://t.co/2i6DQMzUdk
May 20th 2022, 8:05pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed] filed SEC form 4: Director PYOTT DAVID E I: Transacted Derivative Securities on 2022-05-18. https://t.co/gHmENSV0xX
May 20th 2022, 8:05pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed] filed SEC form 4: Director HAMBURG MARGARET A: Transacted Derivative Securities on 2022-05-18… https://t.co/VtgVSSOHZH
May 20th 2022, 8:05pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed] filed SEC form 4: Director Reitan Colleen F: Transacted Derivative Securities on 2022-05-18. https://t.co/5rEALa1I9J
May 20th 2022, 8:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.